四种检测不同疾病患者纤维蛋白原降解产物方法的比较研究。 - Suppr

Suppr

超能文献

A comparative study of four methods for detecting fibrinogen degradation products in patients with various diseases.

作者信息

Thomas D P, Niewiarowski S, Myers A R, Bloch K J, Colman R W

出版信息

N Engl J Med. 1970 Sep 24;283(13):663-8. doi: 10.1056/NEJM197009242831301.

DOI:10.1056/NEJM197009242831301

PMID:4247823

Abstract

摘要

相似文献

A comparative study of four methods for detecting fibrinogen degradation products in patients with various diseases.

N Engl J Med. 1970 Sep 24;283(13):663-8. doi: 10.1056/NEJM197009242831301.

[Measurement of fibrinogen degradation products: its usefulness in consumption coagulopathies].

Union Med Can. 1973 Jan;102(1):66-9.

Hyperfibrinolysis in cirrhosis.

Am J Gastroenterol. 1973 Sep;60(3):280-9.

The clinical significance of fibrinogen degradation products.

Semin Thromb Hemost. 1982 Oct;8(4):302-30. doi: 10.1055/s-2007-1005060.

Measurement of fibrinogen and fibrin degradation products in serum by staphylococcal clumping test.

J Lab Clin Med. 1970 Jan;75(1):93-108.

Detection of hypercoagulable states with protamine sulphate tests.

Acta Univ Carol Med Monogr. 1972;52:185-8.

Intravascular coagulation-fibrinolysis (ICF) syndrome.

Ann Clin Lab Sci (1971). 1972 Jan-Feb;2(1):26-30.

[Natural inhibitors of fibrinolysis and thrombohemorrhagic phenomena].

Pathol Eur. 1969;4:Suppl 1:9-286.

[Fibrinolytic activity of the blood and synovial fluid in patients with rheumatoid arthritis].

Ter Arkh. 1986;58(7):73-7.

Antihaemophilic factor A (F VIII) and serum fibrin-fibrinogen degradation products in hepatic cirrhosis.

Scand J Haematol. 1973;11(2):148-52. doi: 10.1111/j.1600-0609.1973.tb00109.x.

引用本文的文献

Biomarkers in Venous Thrombosis: Diagnostic Potential and Limitations.

Biology (Basel). 2025 Jul 1;14(7):800. doi: 10.3390/biology14070800.

The discovery and identification of a candidate proteomic biomarker of active tuberculosis.

BMC Infect Dis. 2013 Oct 29;13:506. doi: 10.1186/1471-2334-13-506.

Disseminated intravascular coagulation (DIC) and rhabdomyolysis in fulminant varicella infection--case report and review of the literature.

Infection. 1998 Sep-Oct;26(5):306-8. doi: 10.1007/BF02962254.

The detection of fibrinogen-fibrin degradation products by means of a new antibody-coated latex particle.

J Clin Pathol. 1972 Aug;25(8):680-2. doi: 10.1136/jcp.25.8.680.

Modification by drugs of urinary fibrin/fibrinogen degradation products in glomerulonephritis.

Br Med J. 1972 Jul 29;3(5821):255-60. doi: 10.1136/bmj.3.5821.255.

A comparison of the TRCII and latex-particle tests for the titration of FR-antigen.

J Clin Pathol. 1972 Sep;25(9):757-61. doi: 10.1136/jcp.25.9.757.

The origin of fibrin breakdown products and the interpretation of their appearance in the circulation.

J Clin Pathol. 1972 Mar;25(3):185-90. doi: 10.1136/jcp.25.3.185.

The production and testing of staphylococci with clumping factor activity for use in the assay of fibrinogen degradation products.

J Clin Pathol. 1973 May;26(5):377-80. doi: 10.1136/jcp.26.5.377.

Immunobiology of fibrinogen. Emergence of neoantigenic expressions during physiologic cleavage in vitro and in vivo.

J Clin Invest. 1973 Feb;52(2):273-82. doi: 10.1172/JCI107183.

Consumption coagulopathy in a child with congenital cyanotic heart disease and its treatment with heparin.

Indian J Pediatr. 1975 Jan;42(324):17-21. doi: 10.1007/BF02753611.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验